Blueberries Medical Dividend Coverage

What does Blueberries Medical do? Blueberries Medical Corp. generates revenue through the production and distribution of psychoactive and non-psychoactive cannabis by-products, focusing on medicinal cannabis and related products. The company develops and supplies medicinal-grade Cannabis oil extracts, medical flowers, and cannabis-derived ingredients such as high and low THC, CBD, and other cannabinoids. Its subsidiaries, including Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc., and SATIN S.A.S., operate in Colombia as licensed producers and distributors of medicinal cannabis products. Blueberries SAS specifically handles the cultivation, growth, and development of medicinal cannabis within Colombia's regulatory framework. The primary buyers of Blueberries Medical Corp.'s products are medical cannabis consumers and healthcare providers seeking medicinal-grade cannabis extracts and derivatives. The company serves the medicinal cannabis segment, targeting patients requiring therapeutic treatments through non-psychoactive and psychoactive cannabis products. Blueberries Research Corporation (BRC) supports the development of new cannabis-derived ingredients, while BBV Labs focuses on processing and commercializing these products for medical use. Blueberries Medical Corp. operates through its subsidiaries to manage cultivation, processing, and distribution across Colombia. The firm's product portfolio includes medicinal-grade Cannabis oil extracts, medical flowers, and cannabinoid-based ingredients, which are supplied to the medical cannabis market. Blueberries SAS, as a licensed producer, ensures compliance with Colombian regulations while distributing products to healthcare providers and patients requiring medicinal cannabis solutions. Blueberries Medical is one of the most popular companies on Eulerpool.